Integrated Proteins Limited Board Meeting Outcome: Company Secretary Changes

2 min read     Updated on 30 Dec 2025, 01:52 PM
scanx
Reviewed by
Shriram SScanX News Team
Overview

Integrated Proteins Limited conducted a board meeting on December 30, 2025, resulting in key management changes. The company accepted Ms. Palak Chauhan's resignation as Company Secretary and Compliance Officer, citing career transition reasons, and appointed Mr. Girish Kalwani, a qualified Company Secretary, to the same position effective December 31, 2025.

28628569

*this image is generated using AI for illustrative purposes only.

Integrated Proteins Limited has announced key changes in its management structure following a board meeting conducted on December 30, 2025. The company has accepted the resignation of its Company Secretary and appointed a replacement in the same role, as disclosed in its regulatory filing to BSE Limited.

Board Meeting Outcomes

The board of directors convened at the company's registered office on Tuesday, December 30, 2025, from 1:00 PM to 1:30 PM to address important personnel matters. The meeting resulted in two significant decisions regarding the Company Secretary and Compliance Officer position, conducted pursuant to Regulation 30 and Schedule III of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Decision Type: Details
Meeting Date: December 30, 2025
Meeting Duration: 1:00 PM to 1:30 PM
Venue: Registered Office
Key Decisions: Resignation acceptance and new appointment
Managing Director: Karanj Dharmeshbhay (DIN: 10848249)

Resignation of Ms. Palak Chauhan

Ms. Palak Chauhan submitted her resignation from the position of Company Secretary and Compliance Officer, which was accepted by the board with effect from December 30, 2025. In her resignation letter dated December 30, 2025, Ms. Chauhan stated her intention to pursue an alternate career outside the organization.

Parameter: Details
Outgoing Officer: Ms. Palak Chauhan
ACS Number: 77263
ECSIN: RA077263G000046716
Effective Date: Close of business hours, December 30, 2025
Reason: Career transition outside organization
Material Reasons: None beyond career change

Ms. Chauhan confirmed in her resignation letter that there were no material reasons for her departure other than her career decision. She expressed gratitude to the board of directors, senior management, and colleagues for their support during her tenure.

Appointment of Mr. Girish Kalwani

The board simultaneously approved the appointment of Mr. Girish Kalwani as the new Company Secretary and Compliance Officer, designated as Key Managerial Personnel effective December 31, 2025. Mr. Kalwani holds the qualification of Company Secretary with membership number A57701.

Parameter: Details
New Appointee: Mr. Girish Kalwani
Membership Number: A57701
Effective Date: December 31, 2025
Designation: Company Secretary & Compliance Officer
Status: Key Managerial Personnel

Professional Background

Mr. Kalwani brings relevant expertise to his new role as an Associate Member of the Institute of Company Secretaries of India. According to the company's disclosure, he is described as a highly motivated, detail-oriented professional with a strong academic foundation in corporate law, governance, and compliance.

Regulatory Compliance

The appointments and resignations were conducted in accordance with the provisions of Section 203 of the Companies Act 2013 and reported under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The company has fulfilled all necessary disclosure requirements and will submit the required forms with the Registrar of Companies. The official communication was signed by Managing Director Karanj Dharmeshbhay and filed with BSE Limited at Phiroze Jeejeebhoy Tower, Dalal Street, Mumbai.

Historical Stock Returns for Integrated Proteins

1 Day5 Days1 Month6 Months1 Year5 Years
-4.99%-9.91%-14.37%-26.05%-51.17%+904.32%
Integrated Proteins
View in Depthredirect
like18
dislike

Integrated Proteins Limited Receives BSE Trading Approval for Warrant Conversion

1 min read     Updated on 31 Jul 2025, 03:15 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

Integrated Proteins Limited has successfully obtained BSE trading approval for 1.55 crore equity shares issued through warrant conversion on a preferential basis to non-promoters at ₹11.25 per share. The approval became effective on December 18, 2025, completing the warrant conversion process that was initially considered by the board in August 2025, resulting in expansion of the company's equity base.

15500764

*this image is generated using AI for illustrative purposes only.

Integrated Proteins Limited has received trading approval from BSE Limited for 1.55 crore equity shares issued through warrant conversion on a preferential basis to non-promoters. The approval, effective from December 18, 2025, marks the completion of the warrant conversion process that was initially scheduled for board consideration in August 2025.

Trading Approval Details

The company has secured BSE trading approval for the following equity shares:

Parameter: Details
Number of Shares: 1,55,10,000 equity shares
Face Value: ₹10.00 per share
Premium: ₹1.25 per share
Issue Price: ₹11.25 per share
Distinctive Numbers: 3675201 to 19185200
Allottees: Non-promoters
Effective Date: December 18, 2025

Regulatory Compliance and Documentation

The announcement was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Managing Director Karanj Dharmeshbhai Doshi (DIN: 10848249) signed the official intimation to BSE on December 18, 2025.

BSE Limited issued its approval letter (Reference: LOD/PREF/KM/342/2025-2026) on December 17, 2025, confirming that the securities are listed on the exchange effective from December 18, 2025. The exchange also issued Notice No. 20251217-39 to inform trading members about the new listings.

Background and Previous Developments

This development follows the company's earlier announcement of a board meeting scheduled for August 7, 2025, where the conversion of convertible equity warrants into equity shares was considered. The board had deliberated on the conversion of convertible equity warrants and their subsequent allotment to eligible non-promoter warrant holders.

Impact on Capital Structure

The conversion of warrants to equity shares has resulted in an increase in the company's paid-up capital and altered the overall shareholding pattern. The issuance of 1.55 crore new equity shares to non-promoters represents a significant expansion of the company's equity base, potentially diluting existing shareholdings while strengthening the capital structure.

Historical Stock Returns for Integrated Proteins

1 Day5 Days1 Month6 Months1 Year5 Years
-4.99%-9.91%-14.37%-26.05%-51.17%+904.32%
Integrated Proteins
View in Depthredirect
like19
dislike
Explore Other Articles
32.54
-1.71
(-4.99%)